Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
22,430 articles
MercadoLibre Integrates AI Deeper: Can It Boost Conversion Rates?
MELI deepens AI across search, ads and support, lifting conversions as items sold jump 43% and GMV grows 37% in Q4 2025.
The Branches of North Attleboro Earns Benchmark Senior Living's Annual "Resident & Family Connection Award" for Outstanding Satisfaction
Assisted Living Community in North Attleboro, Mass., Recognized for Achieving Highest Satisfaction Out of All 70 Benchmark Communities NORTH...
Coushatta Casino Resort Sets May Opening of New Luxury Hotel Tower
Expansion brings total guest rooms beyond 1,000, reinforcing position as Louisiana's largest casino resort KINDER, La., March 23, 2026 /PRNewswire/...
Coushatta Casino Resort Sets May Opening of New Luxury Hotel Tower
Expansion brings total guest rooms beyond 1,000, reinforcing position as Louisiana's largest casino resort KINDER, La., March 23, 2026 /PRNewswire/...
Coushatta Casino Resort Sets May Opening of New Luxury Hotel Tower
Expansion brings total guest rooms beyond 1,000, reinforcing position as Louisiana's largest casino resort KINDER, La., March 23, 2026 /PRNewswire/...
📰
Why GE Vernova Stock Popped Today
It's a bullish beginning to the week for this industrials stalwart.
📰
Why GE Vernova Stock Popped Today
It's a bullish beginning to the week for this industrials stalwart.
📰
Palantir Surges 5% Monday: What the Pentagon’s Maven AI Decision Means for PLTR
Palantir Technologies (NASDAQ:PLTR) shares spiked 5% in Monday morning trading, with shares moving closer to the $160 level. The catalyst is clear...
Is Elliott's stake in Synopsys stock your cue to buy?
Synopsys (NASDAQ: SNPS) is in focus this morning following reports that activist investor Elliott Investment Management has built a...
📰
Why Broadcom Stock Popped Today
Broadcom earned $5 a share last year. Next year it could earn $20.
📰
Why Broadcom Stock Popped Today
Broadcom earned $5 a share last year. Next year it could earn $20.
📰
Standard Dental Labs Inc. Engages Strategic Advisor to Support Lab Acquisition Strategy
ORLANDO, Fla., March 23, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. ("SDL" or the "Company") today announced it has entered into an...
📰
Boeing vs Honeywell vs 3M: Which Dip Is the Best Buy Right Now?
Boeing (NYSE: BA), Honeywell (NASDAQ: HON), and 3M (NYSE: MMM) have all pulled back sharply over the past month. Each just reported Q4 2025 earnings,...
TotalEnergies Released From $1 Billion US Offshore Wind Lease
The Trump administration released TotalEnergies SE from $1 billion in offshore wind leases so the French energy giant can redirect those funds into...
📰
Urbana Corporation Announces Additional Investment in Tetra Digital Group
/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./
TORONTO, March 23, 2026 (GLOBE NEWSWIRE) -- Urbana Corporation...
Can Workday's Collaboration With Harness Fuel Its Shares?
WDAY expands AI-driven software delivery through its partnership with Harness, boosting automation, security validation and faster innovation for...
Can Workday's Collaboration With Harness Fuel Its Shares?
WDAY expands AI-driven software delivery through its partnership with Harness, boosting automation, security validation and faster innovation for...
Can Workday's Collaboration With Harness Fuel Its Shares?
WDAY expands AI-driven software delivery through its partnership with Harness, boosting automation, security validation and faster innovation for...
Why Are Palantir Shares Surging On Monday?
Palantir Technologies Inc. (NASDAQ:PLTR) shares are climbing Monday. The rally follows a mix of geopolitical relief and significant military contract...
Why Are Palantir Shares Surging On Monday?
Palantir Technologies Inc. (NASDAQ:PLTR) shares are climbing Monday. The rally follows a mix of geopolitical relief and significant military contract...
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch
By David Bautz, PhD
NASDAQ: TNXP
READ THE FULL TNXP RESEARCH REPORT
Business Update
Encouraging Initial Data from Tonmya™ Launch
Following the...
Geopolitical Thaw: Why this Rally has Legs
Ultimately, Wall Street thrives on the resolution of uncertainty. With the immediate threat of conflict cooling and technical indicators pointing...
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch
By David Bautz, PhD
NASDAQ: TNXP
READ THE FULL TNXP RESEARCH REPORT
Business Update
Encouraging Initial Data from Tonmya™ Launch
Following the...
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch
By David Bautz, PhD
NASDAQ: TNXP
READ THE FULL TNXP RESEARCH REPORT
Business Update
Encouraging Initial Data from Tonmya™ Launch
Following the...
Geopolitical Thaw: Why this Rally has Legs
Ultimately, Wall Street thrives on the resolution of uncertainty. With the immediate threat of conflict cooling and technical indicators pointing...
Geopolitical Thaw: Why this Rally has Legs
Ultimately, Wall Street thrives on the resolution of uncertainty. With the immediate threat of conflict cooling and technical indicators pointing...
TNXP: ~2500 Patients Have Initiated Treatment with Tonmya Following November 2025 Commercial Launch
By David Bautz, PhD
NASDAQ: TNXP
READ THE FULL TNXP RESEARCH REPORT
Business Update
Encouraging Initial Data from Tonmya™ Launch
Following the...
Geopolitical Thaw: Why this Rally has Legs
Ultimately, Wall Street thrives on the resolution of uncertainty. With the immediate threat of conflict cooling and technical indicators pointing...
Geopolitical Thaw: Why this Rally has Legs
Ultimately, Wall Street thrives on the resolution of uncertainty. With the immediate threat of conflict cooling and technical indicators pointing...
VRT Benefits From Robust AI Infrastructure Demand: More Upside Ahead?
Vertiv rides on surging AI infrastructure demand, with soaring orders, backlog growth, and NVIDIA collaboration signaling further upside potential.
VRT Benefits From Robust AI Infrastructure Demand: More Upside Ahead?
Vertiv rides on surging AI infrastructure demand, with soaring orders, backlog growth, and NVIDIA collaboration signaling further upside potential.
VRT Benefits From Robust AI Infrastructure Demand: More Upside Ahead?
Vertiv rides on surging AI infrastructure demand, with soaring orders, backlog growth, and NVIDIA collaboration signaling further upside potential.
📰
If You Invested $1000 In iShares Russell 1000 Growth Fund Stock 10 Years Ago, You Would Have This Much Today
iShares Russell 1000 Growth Fund (NYSE:IWF) has outperformed the market over the past 10 years by 3.56% on an annualized basis producing an average...
📰
Berkshire Hathaway Is Buying Back Its Own Stock for the First Time Since 2024. Here's What It Signals.
There are subtle but important clues in every decision a company makes, as well as every decision it doesn't make.
Reddit Rides on Solid Momentum in Ad Business: A Sign of More Upside?
RDDT's ad business surges with 75% revenue growth and rising advertiser demand, as new AI tools and engagement gain power in its expansion.
Reddit Rides on Solid Momentum in Ad Business: A Sign of More Upside?
RDDT's ad business surges with 75% revenue growth and rising advertiser demand, as new AI tools and engagement gain power in its expansion.
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma
Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma
Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
Reddit Rides on Solid Momentum in Ad Business: A Sign of More Upside?
RDDT's ad business surges with 75% revenue growth and rising advertiser demand, as new AI tools and engagement gain power in its expansion.
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma
Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
FDA Approves BMY's Opdivo Label Expansion in Classical Hodgkin Lymphoma
Bristol Myers expands Opdivo's reach with new U.S. and EU approvals in Hodgkin lymphoma, strengthening its immunotherapy leadership and growth...
This Red Rock Resorts Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
This Red Rock Resorts Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
This Red Rock Resorts Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades...
📰
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs
Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.